We are live on
!
Find out more
Pfizer
PFE
PFE
2,903 hedge funds and large institutions have $93B invested in Pfizer in 2025 Q4 according to their latest regulatory filings, with 325 funds opening new positions, 1,075 increasing their positions, 1,266 reducing their positions, and 171 closing their positions.
New
Increased
Maintained
Reduced
Closed
90% more first-time investments, than exits
New positions opened: 325 | Existing positions closed: 171
3% more funds holding
Funds holding: 2,809 → 2,903 (+94)
1.83% more ownership
Funds ownership: 63.85% → 65.68% (+1.8%)
1% more capital invested
Capital invested by funds: $92.5B → $93B (+$491M)
11% less funds holding in top 10
Funds holding in top 10: 35 → 31 (-4)
15% less repeat investments, than reductions
Existing positions increased: 1,075 | Existing positions reduced: 1,266
19% less call options, than puts
Call options by funds: $2.6B | Put options by funds: $3.2B
Holders
2,903
Holders Change
+94
Holders Change %
+3.35%
% of All Funds
35.32%
Holding in Top 10
31
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-11.43%
% of All Funds
0.38%
New
325
Increased
1,075
Reduced
1,266
Closed
171
Calls
$2.6B
Puts
$3.2B
Net Calls
-$593M
Net Calls Change
-$143M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$362M |
| 2 |
Bank of New York Mellon
New York
|
+$342M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$189M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$184M |
| 5 |
Goldman Sachs
New York
|
+$183M |
